Performance evaluation of BD FACSPresto™ point of care CD4 analyzer to enumerate CD4 counts for monitoring HIV infected individuals in Nigeria.
Identifieur interne : 000B31 ( Ncbi/Merge ); précédent : 000B30; suivant : 000B32Performance evaluation of BD FACSPresto™ point of care CD4 analyzer to enumerate CD4 counts for monitoring HIV infected individuals in Nigeria.
Auteurs : Olubunmi Ruth Negedu-Momoh [Nigeria] ; Feyisayo Ebenezer Jegede [Nigeria] ; Ali Yakubu [Nigeria] ; Oluseyi Balogun [Nigeria] ; Musa Abdullahi [Nigeria] ; Titilope Badru [Nigeria] ; Edward Adekola Oladele [Nigeria] ; Chinedu Agbakwuru [Nigeria] ; Hadiza Khamofu [Nigeria] ; Kwasi Torpey [Nigeria]Source :
- PloS one [ 1932-6203 ] ; 2017.
Descripteurs français
- KwdFr :
- Adolescent, Adulte, Adulte d'âge moyen, Femelle, Humains, Infections à VIH (immunologie), Infections à VIH (sang), Jeune adulte, Lymphocytes T CD4+ (immunologie), Lymphocytes T CD4+ (physiologie), Mâle, Nigeria, Numération des lymphocytes CD4 (), Pays en voie de développement, Population rurale, Prélèvement sanguin (), Reproductibilité des résultats, Sensibilité et spécificité, Sujet âgé, Systèmes automatisés lit malade.
- MESH :
- immunologie : Infections à VIH, Lymphocytes T CD4+.
- physiologie : Lymphocytes T CD4+.
- sang : Infections à VIH.
- Adolescent, Adulte, Adulte d'âge moyen, Femelle, Humains, Jeune adulte, Mâle, Nigeria, Numération des lymphocytes CD4, Pays en voie de développement, Population rurale, Prélèvement sanguin, Reproductibilité des résultats, Sensibilité et spécificité, Sujet âgé, Systèmes automatisés lit malade.
English descriptors
- KwdEn :
- Adolescent, Adult, Aged, Blood Specimen Collection (methods), CD4 Lymphocyte Count (methods), CD4-Positive T-Lymphocytes (immunology), CD4-Positive T-Lymphocytes (physiology), Developing Countries, Female, HIV Infections (blood), HIV Infections (immunology), Humans, Male, Middle Aged, Nigeria, Point-of-Care Systems, Reproducibility of Results, Rural Population, Sensitivity and Specificity, Young Adult.
- MESH :
- blood : HIV Infections.
- immunology : CD4-Positive T-Lymphocytes, HIV Infections.
- methods : Blood Specimen Collection, CD4 Lymphocyte Count.
- physiology : CD4-Positive T-Lymphocytes.
- Adolescent, Adult, Aged, Developing Countries, Female, Humans, Male, Middle Aged, Nigeria, Point-of-Care Systems, Reproducibility of Results, Rural Population, Sensitivity and Specificity, Young Adult.
Abstract
Despite the upsurge in support and intervention of donor agencies in HIV care and treatment programing in Sub-Sahara African, antiretroviral (ART) programs are still confronted with access and coverage challenges which influence enrolment of new patients. This study investigated the validity of point of care BD FACSPresto™ CD4 analyzer for CD4+ cell count, overall agreement, correlation, sensitivity, and specificity in comparison to a reference standard flow cytometry method. We also assessed the feasibility of use among non-laboratorians.
DOI: 10.1371/journal.pone.0178037
PubMed: 28542359
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000651
- to stream PubMed, to step Curation: 000651
- to stream PubMed, to step Checkpoint: 000651
Links to Exploration step
pubmed:28542359Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Performance evaluation of BD FACSPresto™ point of care CD4 analyzer to enumerate CD4 counts for monitoring HIV infected individuals in Nigeria.</title><author><name sortKey="Negedu Momoh, Olubunmi Ruth" sort="Negedu Momoh, Olubunmi Ruth" uniqKey="Negedu Momoh O" first="Olubunmi Ruth" last="Negedu-Momoh">Olubunmi Ruth Negedu-Momoh</name><affiliation wicri:level="1"><nlm:affiliation>Family Health International (FHI360), Garki- Abuja, Nigeria.</nlm:affiliation><country xml:lang="fr">Nigeria</country><wicri:regionArea>Family Health International (FHI360), Garki- Abuja</wicri:regionArea><wicri:noRegion>Garki- Abuja</wicri:noRegion></affiliation></author><author><name sortKey="Jegede, Feyisayo Ebenezer" sort="Jegede, Feyisayo Ebenezer" uniqKey="Jegede F" first="Feyisayo Ebenezer" last="Jegede">Feyisayo Ebenezer Jegede</name><affiliation wicri:level="1"><nlm:affiliation>Family Health International (FHI360), Garki- Abuja, Nigeria.</nlm:affiliation><country xml:lang="fr">Nigeria</country><wicri:regionArea>Family Health International (FHI360), Garki- Abuja</wicri:regionArea><wicri:noRegion>Garki- Abuja</wicri:noRegion></affiliation></author><author><name sortKey="Yakubu, Ali" sort="Yakubu, Ali" uniqKey="Yakubu A" first="Ali" last="Yakubu">Ali Yakubu</name><affiliation wicri:level="1"><nlm:affiliation>Murtala Mohammed Specialist Hospital, Kano, Nigeria.</nlm:affiliation><country xml:lang="fr">Nigeria</country><wicri:regionArea>Murtala Mohammed Specialist Hospital, Kano</wicri:regionArea><wicri:noRegion>Kano</wicri:noRegion></affiliation></author><author><name sortKey="Balogun, Oluseyi" sort="Balogun, Oluseyi" uniqKey="Balogun O" first="Oluseyi" last="Balogun">Oluseyi Balogun</name><affiliation wicri:level="1"><nlm:affiliation>Family Health International (FHI360), Garki- Abuja, Nigeria.</nlm:affiliation><country xml:lang="fr">Nigeria</country><wicri:regionArea>Family Health International (FHI360), Garki- Abuja</wicri:regionArea><wicri:noRegion>Garki- Abuja</wicri:noRegion></affiliation></author><author><name sortKey="Abdullahi, Musa" sort="Abdullahi, Musa" uniqKey="Abdullahi M" first="Musa" last="Abdullahi">Musa Abdullahi</name><affiliation wicri:level="1"><nlm:affiliation>Murtala Mohammed Specialist Hospital, Kano, Nigeria.</nlm:affiliation><country xml:lang="fr">Nigeria</country><wicri:regionArea>Murtala Mohammed Specialist Hospital, Kano</wicri:regionArea><wicri:noRegion>Kano</wicri:noRegion></affiliation></author><author><name sortKey="Badru, Titilope" sort="Badru, Titilope" uniqKey="Badru T" first="Titilope" last="Badru">Titilope Badru</name><affiliation wicri:level="1"><nlm:affiliation>Family Health International (FHI360), Garki- Abuja, Nigeria.</nlm:affiliation><country xml:lang="fr">Nigeria</country><wicri:regionArea>Family Health International (FHI360), Garki- Abuja</wicri:regionArea><wicri:noRegion>Garki- Abuja</wicri:noRegion></affiliation></author><author><name sortKey="Oladele, Edward Adekola" sort="Oladele, Edward Adekola" uniqKey="Oladele E" first="Edward Adekola" last="Oladele">Edward Adekola Oladele</name><affiliation wicri:level="1"><nlm:affiliation>Family Health International (FHI360), Garki- Abuja, Nigeria.</nlm:affiliation><country xml:lang="fr">Nigeria</country><wicri:regionArea>Family Health International (FHI360), Garki- Abuja</wicri:regionArea><wicri:noRegion>Garki- Abuja</wicri:noRegion></affiliation></author><author><name sortKey="Agbakwuru, Chinedu" sort="Agbakwuru, Chinedu" uniqKey="Agbakwuru C" first="Chinedu" last="Agbakwuru">Chinedu Agbakwuru</name><affiliation wicri:level="1"><nlm:affiliation>Family Health International (FHI360), Garki- Abuja, Nigeria.</nlm:affiliation><country xml:lang="fr">Nigeria</country><wicri:regionArea>Family Health International (FHI360), Garki- Abuja</wicri:regionArea><wicri:noRegion>Garki- Abuja</wicri:noRegion></affiliation></author><author><name sortKey="Khamofu, Hadiza" sort="Khamofu, Hadiza" uniqKey="Khamofu H" first="Hadiza" last="Khamofu">Hadiza Khamofu</name><affiliation wicri:level="1"><nlm:affiliation>Family Health International (FHI360), Garki- Abuja, Nigeria.</nlm:affiliation><country xml:lang="fr">Nigeria</country><wicri:regionArea>Family Health International (FHI360), Garki- Abuja</wicri:regionArea><wicri:noRegion>Garki- Abuja</wicri:noRegion></affiliation></author><author><name sortKey="Torpey, Kwasi" sort="Torpey, Kwasi" uniqKey="Torpey K" first="Kwasi" last="Torpey">Kwasi Torpey</name><affiliation wicri:level="1"><nlm:affiliation>Family Health International (FHI360), Garki- Abuja, Nigeria.</nlm:affiliation><country xml:lang="fr">Nigeria</country><wicri:regionArea>Family Health International (FHI360), Garki- Abuja</wicri:regionArea><wicri:noRegion>Garki- Abuja</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2017">2017</date><idno type="RBID">pubmed:28542359</idno><idno type="pmid">28542359</idno><idno type="doi">10.1371/journal.pone.0178037</idno><idno type="wicri:Area/PubMed/Corpus">000651</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000651</idno><idno type="wicri:Area/PubMed/Curation">000651</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000651</idno><idno type="wicri:Area/PubMed/Checkpoint">000651</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000651</idno><idno type="wicri:Area/Ncbi/Merge">000B31</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Performance evaluation of BD FACSPresto™ point of care CD4 analyzer to enumerate CD4 counts for monitoring HIV infected individuals in Nigeria.</title><author><name sortKey="Negedu Momoh, Olubunmi Ruth" sort="Negedu Momoh, Olubunmi Ruth" uniqKey="Negedu Momoh O" first="Olubunmi Ruth" last="Negedu-Momoh">Olubunmi Ruth Negedu-Momoh</name><affiliation wicri:level="1"><nlm:affiliation>Family Health International (FHI360), Garki- Abuja, Nigeria.</nlm:affiliation><country xml:lang="fr">Nigeria</country><wicri:regionArea>Family Health International (FHI360), Garki- Abuja</wicri:regionArea><wicri:noRegion>Garki- Abuja</wicri:noRegion></affiliation></author><author><name sortKey="Jegede, Feyisayo Ebenezer" sort="Jegede, Feyisayo Ebenezer" uniqKey="Jegede F" first="Feyisayo Ebenezer" last="Jegede">Feyisayo Ebenezer Jegede</name><affiliation wicri:level="1"><nlm:affiliation>Family Health International (FHI360), Garki- Abuja, Nigeria.</nlm:affiliation><country xml:lang="fr">Nigeria</country><wicri:regionArea>Family Health International (FHI360), Garki- Abuja</wicri:regionArea><wicri:noRegion>Garki- Abuja</wicri:noRegion></affiliation></author><author><name sortKey="Yakubu, Ali" sort="Yakubu, Ali" uniqKey="Yakubu A" first="Ali" last="Yakubu">Ali Yakubu</name><affiliation wicri:level="1"><nlm:affiliation>Murtala Mohammed Specialist Hospital, Kano, Nigeria.</nlm:affiliation><country xml:lang="fr">Nigeria</country><wicri:regionArea>Murtala Mohammed Specialist Hospital, Kano</wicri:regionArea><wicri:noRegion>Kano</wicri:noRegion></affiliation></author><author><name sortKey="Balogun, Oluseyi" sort="Balogun, Oluseyi" uniqKey="Balogun O" first="Oluseyi" last="Balogun">Oluseyi Balogun</name><affiliation wicri:level="1"><nlm:affiliation>Family Health International (FHI360), Garki- Abuja, Nigeria.</nlm:affiliation><country xml:lang="fr">Nigeria</country><wicri:regionArea>Family Health International (FHI360), Garki- Abuja</wicri:regionArea><wicri:noRegion>Garki- Abuja</wicri:noRegion></affiliation></author><author><name sortKey="Abdullahi, Musa" sort="Abdullahi, Musa" uniqKey="Abdullahi M" first="Musa" last="Abdullahi">Musa Abdullahi</name><affiliation wicri:level="1"><nlm:affiliation>Murtala Mohammed Specialist Hospital, Kano, Nigeria.</nlm:affiliation><country xml:lang="fr">Nigeria</country><wicri:regionArea>Murtala Mohammed Specialist Hospital, Kano</wicri:regionArea><wicri:noRegion>Kano</wicri:noRegion></affiliation></author><author><name sortKey="Badru, Titilope" sort="Badru, Titilope" uniqKey="Badru T" first="Titilope" last="Badru">Titilope Badru</name><affiliation wicri:level="1"><nlm:affiliation>Family Health International (FHI360), Garki- Abuja, Nigeria.</nlm:affiliation><country xml:lang="fr">Nigeria</country><wicri:regionArea>Family Health International (FHI360), Garki- Abuja</wicri:regionArea><wicri:noRegion>Garki- Abuja</wicri:noRegion></affiliation></author><author><name sortKey="Oladele, Edward Adekola" sort="Oladele, Edward Adekola" uniqKey="Oladele E" first="Edward Adekola" last="Oladele">Edward Adekola Oladele</name><affiliation wicri:level="1"><nlm:affiliation>Family Health International (FHI360), Garki- Abuja, Nigeria.</nlm:affiliation><country xml:lang="fr">Nigeria</country><wicri:regionArea>Family Health International (FHI360), Garki- Abuja</wicri:regionArea><wicri:noRegion>Garki- Abuja</wicri:noRegion></affiliation></author><author><name sortKey="Agbakwuru, Chinedu" sort="Agbakwuru, Chinedu" uniqKey="Agbakwuru C" first="Chinedu" last="Agbakwuru">Chinedu Agbakwuru</name><affiliation wicri:level="1"><nlm:affiliation>Family Health International (FHI360), Garki- Abuja, Nigeria.</nlm:affiliation><country xml:lang="fr">Nigeria</country><wicri:regionArea>Family Health International (FHI360), Garki- Abuja</wicri:regionArea><wicri:noRegion>Garki- Abuja</wicri:noRegion></affiliation></author><author><name sortKey="Khamofu, Hadiza" sort="Khamofu, Hadiza" uniqKey="Khamofu H" first="Hadiza" last="Khamofu">Hadiza Khamofu</name><affiliation wicri:level="1"><nlm:affiliation>Family Health International (FHI360), Garki- Abuja, Nigeria.</nlm:affiliation><country xml:lang="fr">Nigeria</country><wicri:regionArea>Family Health International (FHI360), Garki- Abuja</wicri:regionArea><wicri:noRegion>Garki- Abuja</wicri:noRegion></affiliation></author><author><name sortKey="Torpey, Kwasi" sort="Torpey, Kwasi" uniqKey="Torpey K" first="Kwasi" last="Torpey">Kwasi Torpey</name><affiliation wicri:level="1"><nlm:affiliation>Family Health International (FHI360), Garki- Abuja, Nigeria.</nlm:affiliation><country xml:lang="fr">Nigeria</country><wicri:regionArea>Family Health International (FHI360), Garki- Abuja</wicri:regionArea><wicri:noRegion>Garki- Abuja</wicri:noRegion></affiliation></author></analytic><series><title level="j">PloS one</title><idno type="eISSN">1932-6203</idno><imprint><date when="2017" type="published">2017</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Aged</term><term>Blood Specimen Collection (methods)</term><term>CD4 Lymphocyte Count (methods)</term><term>CD4-Positive T-Lymphocytes (immunology)</term><term>CD4-Positive T-Lymphocytes (physiology)</term><term>Developing Countries</term><term>Female</term><term>HIV Infections (blood)</term><term>HIV Infections (immunology)</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Nigeria</term><term>Point-of-Care Systems</term><term>Reproducibility of Results</term><term>Rural Population</term><term>Sensitivity and Specificity</term><term>Young Adult</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Femelle</term><term>Humains</term><term>Infections à VIH (immunologie)</term><term>Infections à VIH (sang)</term><term>Jeune adulte</term><term>Lymphocytes T CD4+ (immunologie)</term><term>Lymphocytes T CD4+ (physiologie)</term><term>Mâle</term><term>Nigeria</term><term>Numération des lymphocytes CD4 ()</term><term>Pays en voie de développement</term><term>Population rurale</term><term>Prélèvement sanguin ()</term><term>Reproductibilité des résultats</term><term>Sensibilité et spécificité</term><term>Sujet âgé</term><term>Systèmes automatisés lit malade</term></keywords><keywords scheme="MESH" qualifier="blood" xml:lang="en"><term>HIV Infections</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Infections à VIH</term><term>Lymphocytes T CD4+</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>CD4-Positive T-Lymphocytes</term><term>HIV Infections</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Blood Specimen Collection</term><term>CD4 Lymphocyte Count</term></keywords><keywords scheme="MESH" qualifier="physiologie" xml:lang="fr"><term>Lymphocytes T CD4+</term></keywords><keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>CD4-Positive T-Lymphocytes</term></keywords><keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Infections à VIH</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Aged</term><term>Developing Countries</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Nigeria</term><term>Point-of-Care Systems</term><term>Reproducibility of Results</term><term>Rural Population</term><term>Sensitivity and Specificity</term><term>Young Adult</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Femelle</term><term>Humains</term><term>Jeune adulte</term><term>Mâle</term><term>Nigeria</term><term>Numération des lymphocytes CD4</term><term>Pays en voie de développement</term><term>Population rurale</term><term>Prélèvement sanguin</term><term>Reproductibilité des résultats</term><term>Sensibilité et spécificité</term><term>Sujet âgé</term><term>Systèmes automatisés lit malade</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Despite the upsurge in support and intervention of donor agencies in HIV care and treatment programing in Sub-Sahara African, antiretroviral (ART) programs are still confronted with access and coverage challenges which influence enrolment of new patients. This study investigated the validity of point of care BD FACSPresto™ CD4 analyzer for CD4+ cell count, overall agreement, correlation, sensitivity, and specificity in comparison to a reference standard flow cytometry method. We also assessed the feasibility of use among non-laboratorians.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28542359</PMID><DateCreated><Year>2017</Year><Month>05</Month><Day>25</Day></DateCreated><DateCompleted><Year>2017</Year><Month>09</Month><Day>11</Day></DateCompleted><DateRevised><Year>2017</Year><Month>09</Month><Day>11</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>5</Issue><PubDate><Year>2017</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS ONE</ISOAbbreviation></Journal><ArticleTitle>Performance evaluation of BD FACSPresto™ point of care CD4 analyzer to enumerate CD4 counts for monitoring HIV infected individuals in Nigeria.</ArticleTitle><Pagination><MedlinePgn>e0178037</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0178037</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Despite the upsurge in support and intervention of donor agencies in HIV care and treatment programing in Sub-Sahara African, antiretroviral (ART) programs are still confronted with access and coverage challenges which influence enrolment of new patients. This study investigated the validity of point of care BD FACSPresto™ CD4 analyzer for CD4+ cell count, overall agreement, correlation, sensitivity, and specificity in comparison to a reference standard flow cytometry method. We also assessed the feasibility of use among non-laboratorians.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Blood samples from 300 HIV infected individuals were analyzed for CD4+ T cell and CD4%, using finger prick capillary sample from 150 PMTCT clients and 150 ART clients at Murtala Mohammed Specialist Hospital, Kano, Nigeria. Their venous samples were compared on a flow cytometry reference method using BD FACSCount CD4+ count system. The accuracy of the BD FACSPresto machine in comparison to BD FACSCount was evaluated. Statistical analysis was carried out using STATA (version 12). Bland-Altman method and correlation analysis were used to analyze agreement between both measurements. In addition, sensitivity and specificity of both measurements were determined. Statistical significance was set at p-value <0.05.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The mean bias and limit of agreement for CD4+ count between BD FACSPresto and BD FACS count machine were 7.49 (95% CI: 2.44 to 12.54) and -8.14 to 96.39 respectively. Further analysis revealed close agreement between BD FACSPresto and BD FACSCount with no significant difference between the two methods (p = .0.95). Using a threshold of 500 cells/μL, sensitivity and specificity of BD FACSPresto were 95.1% and 97.1% respectively, compared to BD FACSCount. There was no statistically significant difference in the misclassification between BD FACSPresto and BD FACSCount results (p = 0.23). Furthermore, sensitivity and specificity were similar when BD FACSPresto machine was operated by a nurse or laboratory scientist, there was no substantial difference in testing variability observed between laboratory and non-laboratory operators using the BD FACSPresto analyzer.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Overall, BD FACSPresto Point of Care CD4+ count finger stick capillary blood results is a reliable method in comparison to venous sample cytometry method and no significant difference variability observed between laboratory personnel and non-laboratory operators. The BD FACSPresto is simple, more robust and easy to use equipment without significant variability in reliability by non-laboratory health care workers hence will be a valuable instrument in increasing access and coverage of CD4 estimations in developing countries. The introduction of the BD FACSPresto POC analyzer has a high potential in reducing patients waiting time and improving the overall quality of ART service and clients' satisfaction especially in rural settings.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Negedu-Momoh</LastName><ForeName>Olubunmi Ruth</ForeName><Initials>OR</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-3347-8177</Identifier><AffiliationInfo><Affiliation>Family Health International (FHI360), Garki- Abuja, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jegede</LastName><ForeName>Feyisayo Ebenezer</ForeName><Initials>FE</Initials><AffiliationInfo><Affiliation>Family Health International (FHI360), Garki- Abuja, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yakubu</LastName><ForeName>Ali</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Murtala Mohammed Specialist Hospital, Kano, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Balogun</LastName><ForeName>Oluseyi</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Family Health International (FHI360), Garki- Abuja, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abdullahi</LastName><ForeName>Musa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Murtala Mohammed Specialist Hospital, Kano, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Badru</LastName><ForeName>Titilope</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Family Health International (FHI360), Garki- Abuja, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oladele</LastName><ForeName>Edward Adekola</ForeName><Initials>EA</Initials><AffiliationInfo><Affiliation>Family Health International (FHI360), Garki- Abuja, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agbakwuru</LastName><ForeName>Chinedu</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Family Health International (FHI360), Garki- Abuja, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khamofu</LastName><ForeName>Hadiza</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Family Health International (FHI360), Garki- Abuja, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torpey</LastName><ForeName>Kwasi</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Family Health International (FHI360), Garki- Abuja, Nigeria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Ghana College of Health Sciences, Accra, Ghana.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>05</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2014 Mar 10;9(3):e88928</RefSource><PMID Version="1">24614083</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lab Chip. 2009 May 21;9(10):1357-64</RefSource><PMID Version="1">19417901</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Biotechnol. 2012 Jan;30(1):45-54</RefSource><PMID Version="1">21798607</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Acquir Immune Defic Syndr. 2012 Jul 1;60(3):260-4</RefSource><PMID Version="1">22487589</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013 Jun 25;8(6):e67612</RefSource><PMID Version="1">23825674</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2016 Aug 02;11(8):e0157939</RefSource><PMID Version="1">27483008</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2016 May 25;11(5):e0156266</RefSource><PMID Version="1">27224025</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Infect Dis. 2007 Jan 1;44(1):128-34</RefSource><PMID Version="1">17143828</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Infect Dis. 2016 Apr 15;62(8):1043-8</RefSource><PMID Version="1">26743094</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2012;7(4):e34319</RefSource><PMID Version="1">22536323</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS Res Ther. 2012 Sep 21;9(1):26</RefSource><PMID Version="1">22998738</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS. 2013 Jun 1;27(9):1403-12</RefSource><PMID Version="1">23343913</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2015 Dec 31;10(12):e0145586</RefSource><PMID Version="1">26720601</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J STD AIDS. 2014 Nov;25(13):956-9</RefSource><PMID Version="1">24616116</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 2011 Oct 29;378(9802):1572-9</RefSource><PMID Version="1">21951656</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Acquir Immune Defic Syndr. 2010 Sep;55(1):1-7</RefSource><PMID Version="1">20622679</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biotechnol Adv. 2010 Nov-Dec;28(6):770-81</RefSource><PMID Version="1">20600784</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001800" MajorTopicYN="N">Blood Specimen Collection</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018791" MajorTopicYN="N">CD4 Lymphocyte Count</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015496" MajorTopicYN="N">CD4-Positive T-Lymphocytes</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003906" MajorTopicYN="N">Developing Countries</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015658" MajorTopicYN="N">HIV Infections</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009549" MajorTopicYN="N">Nigeria</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019095" MajorTopicYN="N">Point-of-Care Systems</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012424" MajorTopicYN="N">Rural Population</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>12</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>05</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>5</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>5</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>9</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28542359</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0178037</ArticleId><ArticleId IdType="pii">PONE-D-16-48631</ArticleId><ArticleId IdType="pmc">PMC5444776</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Nigeria</li></country></list><tree><country name="Nigeria"><noRegion><name sortKey="Negedu Momoh, Olubunmi Ruth" sort="Negedu Momoh, Olubunmi Ruth" uniqKey="Negedu Momoh O" first="Olubunmi Ruth" last="Negedu-Momoh">Olubunmi Ruth Negedu-Momoh</name></noRegion><name sortKey="Abdullahi, Musa" sort="Abdullahi, Musa" uniqKey="Abdullahi M" first="Musa" last="Abdullahi">Musa Abdullahi</name><name sortKey="Agbakwuru, Chinedu" sort="Agbakwuru, Chinedu" uniqKey="Agbakwuru C" first="Chinedu" last="Agbakwuru">Chinedu Agbakwuru</name><name sortKey="Badru, Titilope" sort="Badru, Titilope" uniqKey="Badru T" first="Titilope" last="Badru">Titilope Badru</name><name sortKey="Balogun, Oluseyi" sort="Balogun, Oluseyi" uniqKey="Balogun O" first="Oluseyi" last="Balogun">Oluseyi Balogun</name><name sortKey="Jegede, Feyisayo Ebenezer" sort="Jegede, Feyisayo Ebenezer" uniqKey="Jegede F" first="Feyisayo Ebenezer" last="Jegede">Feyisayo Ebenezer Jegede</name><name sortKey="Khamofu, Hadiza" sort="Khamofu, Hadiza" uniqKey="Khamofu H" first="Hadiza" last="Khamofu">Hadiza Khamofu</name><name sortKey="Oladele, Edward Adekola" sort="Oladele, Edward Adekola" uniqKey="Oladele E" first="Edward Adekola" last="Oladele">Edward Adekola Oladele</name><name sortKey="Torpey, Kwasi" sort="Torpey, Kwasi" uniqKey="Torpey K" first="Kwasi" last="Torpey">Kwasi Torpey</name><name sortKey="Yakubu, Ali" sort="Yakubu, Ali" uniqKey="Yakubu A" first="Ali" last="Yakubu">Ali Yakubu</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaGhanaV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000B31 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 000B31 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= SidaGhanaV1
|flux= Ncbi
|étape= Merge
|type= RBID
|clé= pubmed:28542359
|texte= Performance evaluation of BD FACSPresto™ point of care CD4 analyzer to enumerate CD4 counts for monitoring HIV infected individuals in Nigeria.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:28542359" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \
| NlmPubMed2Wicri -a SidaGhanaV1
| This area was generated with Dilib version V0.6.31. |  |